Novo Nordisk is intervening in the lawsuit filed by a drug compounders trade group against the FDA over the agency’s decision ...
While the Super Bowl may not always be the ideal spot for pharma, cultural events like the Oscars can offer a more ...
Despite falling hard since last summer, shares of Novo Nordisk have more than doubled the market's overall performance. The ...
Despite comments made by a Novo Nordisk official this week, the company confirmed to BioSpace that it has no additional ...
Walgreens jumps as Sycamore agrees to $11.45 a share purchase Sycamore Partners agreed to acquire Walgreens Boots (WBA) in a ...
Novo Nordisk says many Australians would be willing to pay the out-of-pocket costs for its blockbuster medicines, which can ...
Novo Nordisk has asked the FDA to stop compounding ... The request follows a similar move by Eli Lilly, which has asked for a ban on other parties making copies of its tirzepatide-based ...
The partnership comes as telehealth companies grapple with restrictions on the sale of some compounded GLP-1s.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback